USSTOCK.TODAY
Market Closed
Log in Sign up

Cardio Diagnostics Holdings Inc(CDIO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

CDIO
CDIO
Cardio Diagnostics Holdings Inc
At close Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$1.65
-0.04 ▼ -2.37%
Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$1.65
+0.00 +0.00%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -2.52Insider Own ⓘ 4.34%Shs Outstand ⓘ 3.0MPerf Week ⓘ -11.76%
Market Cap ⓘ 0.00BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 2.8MPerf Month ⓘ -6.78%
Enterprise Value ⓘ 0.00BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 6.81%Short Float ⓘ 0.17%Perf Quarter ⓘ -18.72%
Income ⓘ -0.01BP/S ⓘ 244.08EPS this Y ⓘ -Inst Trans ⓘ -3.6%Short Ratio ⓘ 0.17Perf Half Y ⓘ 9.27%
Sales ⓘ 0.00BP/B ⓘ 0.85EPS next 5Y ⓘ -ROA ⓘ -87.24%Short Interest ⓘ 0.00MPerf YTD ⓘ -39.11%
Book/sh ⓘ 1.93P/C ⓘ 1.24EPS past 3/5Y ⓘ 56.57% 30.61%ROE ⓘ -93.55%52W High ⓘ -79.14% ($7.91)Perf Year ⓘ -35.55%
Cash/sh ⓘ 1.33P/FCF ⓘ -Sales past 3/5Y ⓘ 149.89% 101.4%ROIC ⓘ -111.19%52W Low ⓘ 70.1% ($0.97)Perf 3Y ⓘ -94.44%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 35.35%Gross Margin ⓘ -2231.9%Volatility(W/M) ⓘ 9.3% 6.94%Perf 5Y ⓘ -
Dividend TTM ⓘ -EV/Sales ⓘ 59.08Sales Y/Y TTM ⓘ -3.78%Oper. Margin ⓘ -42649.75%ATR (14) ⓘ 0.13Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 17.44EPS Q/Q ⓘ 39.98%Profit Margin ⓘ -42721.93%RSI (14) ⓘ 41.66Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 17.44Sales Q/Q ⓘ 25.74%SMA20 ⓘ -4.82% ($1.73)Beta ⓘ 2.27Target Price ⓘ $60
Payout ⓘ -Debt/Eq ⓘ 0.04Earnings ⓘ -SMA50 ⓘ -9.56% ($1.82)Rel Volume ⓘ 1.1Prev Close ⓘ $1.69
Employees ⓘ 15LT Debt/Eq ⓘ 0.02EPS/Sales Surpr. ⓘ -SMA200 ⓘ -20.37% ($2.07)Avg Volume(3M) ⓘ 0.03MPrice ⓘ $1.65
IPO ⓘ 2022/1/14Option/Short ⓘ No/YesTrades ⓘ 311Volume ⓘ 30,779Change ⓘ -2.37%
Company
CDIO CDIOCardio Diagnostics Holdings Inc | NASD | Biotechnology Deep dive

Cardio Diagnostics Holdings, Inc. is a precision medicine diagnostics company that combines artificial intelligence and epigenetics to enable the early detection and assessment of coronary heart disease (CHD). Founded in 2017 and headquartered in Chicago, Illinois, the company operates its business around its blood-based tests, Epi+Gen CHD and PrecisionCHD.

Quote

Over the past 1 year, on the lower side

79% below its 1-year high.

Now $1.65
52w low$0.9752w high$7.91
52W Range10%
Volume ⓘ 30,779

Traded about as much as usual. That is 110% of its average volume.

C
Overall · average, with some caution
We judged 5 of the 8 questions below. 1 rate excellent and 3 need caution.
No data for growth, outlook, dividends, or not applicable.
ETFs holding this stock 2 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Biotechnology

It ranks #541 of 598 in the industry

Based on market cap of $5M.

FAQ

FAQ

What kind of company is CDIO?

CDIO belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of CDIO?

The market cap of CDIO is approximately $5M, ranking 5,569 within its sector.

What is the 52-week high and low for CDIO?

CDIO has recorded a 52-week high of $7.91 and a low of $0.97.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels